- Home
- PSNY vs IRON Comparison
PSNY vs IRON Comparison
Compare PSNY & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNY
- IRON
- Stock Information
- Founded
- PSNY 2017
- IRON 2017
- Country
- PSNY Sweden
- IRON United States
- Employees
- PSNY N/A
- IRON N/A
- Industry
- PSNY Auto Manufacturing
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PSNY Consumer Discretionary
- IRON Health Care
- Exchange
- PSNY Nasdaq
- IRON Nasdaq
- Market Cap
- PSNY 2.3B
- IRON 1.9B
- IPO Year
- PSNY N/A
- IRON N/A
- Fundamental
- Price
- PSNY $1.04
- IRON $48.53
- Analyst Decision
- PSNY Hold
- IRON Strong Buy
- Analyst Count
- PSNY 7
- IRON 10
- Target Price
- PSNY $1.29
- IRON $83.80
- AVG Volume (30 Days)
- PSNY 4.3M
- IRON 408.9K
- Earning Date
- PSNY 03-06-2025
- IRON 05-08-2025
- Dividend Yield
- PSNY N/A
- IRON N/A
- EPS Growth
- PSNY N/A
- IRON N/A
- EPS
- PSNY N/A
- IRON N/A
- Revenue
- PSNY $2,046,740,000.00
- IRON N/A
- Revenue This Year
- PSNY N/A
- IRON N/A
- Revenue Next Year
- PSNY $77.28
- IRON N/A
- P/E Ratio
- PSNY N/A
- IRON N/A
- Revenue Growth
- PSNY N/A
- IRON N/A
- 52 Week Low
- PSNY $0.61
- IRON $25.64
- 52 Week High
- PSNY $1.94
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- PSNY 40.85
- IRON 35.17
- Support Level
- PSNY $1.10
- IRON $51.57
- Resistance Level
- PSNY $1.09
- IRON $53.61
- Average True Range (ATR)
- PSNY 0.05
- IRON 2.16
- MACD
- PSNY -0.01
- IRON -0.42
- Stochastic Oscillator
- PSNY 15.38
- IRON 24.72
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.